DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Barlesi F, Scherpereel A, Gorbunova V. et al.
Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial.
Ann Oncol 2014;
25: 1044-1052
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.